DESCRIPTION:

In this seminar, Dr. Kline will describe platforms utilized to cluster diffuse large B cell lymphomas according to their genetic background and immune environment. Dr. Kline will discuss how these classifiers can and are being utilized to develop precision therapy strategies for diffuse large B cell lymphoma, as well as limitations and challenges of these strategies.

LEARNING OBJECTIVES:

• Become aware of emerging DLBCL classification systems
• Understand how these systems can leverage to develop tailored therapy DLBCL
• Discuss limitations and challenges of DLBCL classification and precision therapy